What Causes Cysts on the Pancreas?

Pancreatic cysts form through several distinct pathways, from inflammation after a bout of pancreatitis to slow-growing tumors to inherited genetic conditions. The most common type, the pseudocyst, develops when digestive enzymes leak from an inflamed or injured pancreas and pool in surrounding tissue. But many cysts found today are neoplastic, meaning they grow from abnormal cell proliferation within the pancreas itself. Because modern imaging picks up pancreatic cysts far more often than it used to, understanding what drives their formation has become increasingly relevant for the millions of people who learn about one during an unrelated scan.

Pseudocysts and the Role of Pancreatitis

The single most common cause of a fluid-filled pocket on or near the pancreas is acute or chronic pancreatitis. When the pancreas becomes inflamed, digestive enzymes that normally flow into the small intestine activate prematurely and begin digesting pancreatic tissue. Fluid rich in those enzymes leaks out and collects in the space around the organ. In roughly half of acute pancreatitis cases, some fluid accumulates in the area surrounding the pancreas, and the body usually reabsorbs it on its own. In about one in ten patients, though, the fluid does not resolve. Instead, the body walls it off with fibrous tissue, forming what clinicians call a pseudocyst.¹

The word “pseudo” matters here. Unlike true cysts, which are lined with a layer of specialized cells, pseudocysts are simply fluid collections surrounded by scar-like tissue. They contain no epithelial lining. That distinction is more than academic: it helps doctors figure out whether a cyst developed from inflammation or from a tumor.

The two leading triggers for the pancreatitis that causes pseudocysts are gallstones and heavy alcohol use. A large study comparing these two causes found that patients with alcohol-related pancreatitis had higher rates of tissue death within the pancreas compared to those whose pancreatitis was caused by gallstones.² More tissue damage generally means more enzyme-rich fluid leaking out, which can translate into a greater chance of pseudocyst formation.

Trauma and Surgical Injury

A blow to the abdomen can injure the pancreas just as effectively as internal inflammation. Car accidents, sports collisions, bicycle handlebar injuries in children, and even surgical procedures near the pancreas can all disrupt the organ enough to trigger enzyme leakage and pseudocyst formation. One reported case involved a fourteen-year-old boy who developed a large pseudocyst after a blunt abdominal injury during a football game.³ The mechanism is essentially the same as in pancreatitis: physical damage to the pancreas causes enzyme leakage, fluid accumulation, and eventually encapsulation by fibrous tissue. These traumatic pseudocysts are particularly worth knowing about in children, where true neoplastic cysts are rare and a history of injury often points directly to the cause.

Neoplastic Cysts That Grow From Abnormal Cells

Not every pancreatic cyst is a byproduct of inflammation. A substantial number are neoplasms, meaning they arise from abnormal cell growth within the pancreas. These are true cysts with an epithelial lining, and they range from entirely benign to potentially cancerous. The four main types that doctors encounter are intraductal papillary mucinous neoplasms (IPMNs), mucinous cystic neoplasms (MCNs), serous cystadenomas, and solid pseudopapillary neoplasms.⁴ Each has a different biology, a different risk profile, and a different typical patient.

Intraductal Papillary Mucinous Neoplasms

IPMNs are mucus-producing growths that develop inside the pancreatic ducts. They are among the most commonly detected pancreatic cysts and are particularly frequent in older adults. The mucus they produce can clog the ducts and cause them to dilate, which is often how these cysts first show up on imaging. IPMNs come in subtypes depending on which duct they involve. Those growing in the main pancreatic duct carry a meaningfully higher risk of progressing to cancer than those found only in smaller branch ducts. One study found that main-duct IPMNs were far more likely to cause dilation of the common bile duct than branch-duct or mixed-type IPMNs, reflecting their more aggressive growth pattern.⁵ The branch-duct variety, while still monitored, is considered lower risk and often watched with periodic imaging rather than removed right away.

Mucinous Cystic Neoplasms

MCNs are a striking example of how a cyst’s biology can be deeply specific. These mucus-producing tumors occur almost exclusively in women. In one large series, 98% of patients with MCNs confirmed by the presence of a characteristic tissue called ovarian-type stroma were female.⁶ That ovarian-type stroma is the defining feature of MCNs, and it expresses receptors for estrogen and progesterone, which likely explains the overwhelming female predominance.⁷

The hormonal connection is not just a curiosity. A recent case report documented an MCN that grew rapidly and ruptured after a woman underwent hormonal stimulation for in vitro fertilization, and the tumor tested positive for estrogen receptors on pathological examination.⁸ MCNs tend to appear in the body or tail of the pancreas rather than the head, and they carry a real, if variable, risk of becoming cancerous over time. For that reason, surgery is typically recommended when an MCN is diagnosed.

Serous Cystadenomas

Serous cystadenomas are the reassuring end of the pancreatic cyst spectrum. They are the second most common type of cystic neoplasm in the pancreas, and they are overwhelmingly benign.⁹ Under a microscope, they consist of small cystic spaces lined by a thin layer of flat cells, with a rich network of tiny blood vessels underneath.¹⁰ They produce a thin, watery fluid rather than the thick mucus seen in IPMNs and MCNs. Most serous cystadenomas are discovered incidentally and never cause symptoms. When they do grow large enough to press on surrounding structures, they can be removed surgically with spleen-preserving techniques.¹¹

Solid Pseudopapillary Neoplasms

Solid pseudopapillary neoplasms are uncommon tumors that typically affect young women. They have both solid and cystic components, and the cystic parts form as areas of the tumor break down internally. Genetically, these tumors are distinctive: about 90% carry activating mutations in a gene involved in cell signaling called beta-catenin.¹² These mutations are acquired, not inherited, meaning they develop in the tumor itself rather than being passed down from a parent. Despite their alarming-sounding name, solid pseudopapillary neoplasms are considered low-grade malignancies, and surgical removal is usually curative.

Inherited Genetic Conditions

Some people develop pancreatic cysts not because of anything that happened to their pancreas, but because of a gene they were born with. Two inherited conditions stand out for their association with pancreatic cyst formation.

Von Hippel-Lindau Disease

Von Hippel-Lindau disease is a hereditary syndrome caused by a mutation in the VHL tumor suppressor gene. People with this condition are prone to developing tumors and cysts in multiple organs, including the brain, kidneys, adrenal glands, and pancreas.¹³ Pancreatic cysts are remarkably common in VHL patients, occurring in roughly 70% of them.¹⁴ Research in laboratory models suggests that loss of the VHL protein disrupts tiny hair-like structures on ductal cells called cilia, and this disruption appears to be an early step in cyst development.

Most of the pancreatic cysts seen in VHL patients are benign, typically simple cysts or serous cystadenomas. But VHL can also give rise to neuroendocrine tumors in the pancreas, making it essential to distinguish harmless cysts from potentially dangerous solid lesions during surveillance.¹⁵

Autosomal Dominant Polycystic Kidney Disease

Autosomal dominant polycystic kidney disease (ADPKD) is best known for filling the kidneys with cysts, but it affects the pancreas too. One imaging study found that about 36% of ADPKD patients had at least one pancreatic cyst, compared to 23% of matched controls.¹⁶ That study also found that people whose ADPKD was caused by a mutation in the PKD2 gene were about six times more likely to have pancreatic cysts than those with PKD1 mutations. A separate study reported a somewhat different prevalence pattern and did not find a significant difference between PKD1 and PKD2 mutation carriers, illustrating that the relationship between genotype and pancreatic cyst risk is still being worked out.¹⁷ Either way, pancreatic cysts in ADPKD are generally simple and benign, and they rarely require treatment on their own.

Autoimmune Pancreatitis

Autoimmune pancreatitis is a condition where the immune system attacks the pancreas, causing inflammation and swelling. It is a well-recognized cause of pseudocyst formation, though it gets less attention than alcohol or gallstone-related pancreatitis. The inflammation narrows the pancreatic ducts and damages the surrounding tissue, and cystic lesions can appear in the segments of the pancreas affected by the autoimmune process.¹⁸ In one documented case, a patient developed multiple cysts during a recurrence of autoimmune pancreatitis, and tissue examination confirmed that the cyst walls were fibrotic and surrounded by the kind of immune cell infiltration characteristic of the disease.¹⁹ These patients often respond to steroid therapy, which can shrink both the pancreatic inflammation and the associated cysts.²⁰

Infectious and Parasitic Causes

In certain parts of the world, a parasitic infection can mimic a pancreatic cyst. Hydatid disease, caused by the tapeworm Echinococcus, most often affects the liver and lungs, but the pancreas is an uncommon site. When a hydatid cyst does form in the pancreas, it can look remarkably similar to a pseudocyst or even a cystic tumor on imaging, sometimes leading to the correct diagnosis being made only after surgery.²¹ One case involved a patient whose pancreatic hydatid cyst grew large enough to compress nearby blood vessels and cause portal hypertension, requiring surgical removal of part of the pancreas and spleen.²² These cases are rare in most Western countries but worth knowing about for people who have lived in or traveled to regions where the parasite is endemic, including parts of the Mediterranean, the Middle East, East Africa, and South America.

Congenital Cysts

True congenital cysts of the pancreas are among the rarest causes. These are cysts that form during fetal development, are present at birth, and are lined by epithelial cells. They are far more unusual than pseudocysts in children, which are typically the result of trauma or an inflammatory episode. A reported case described a child diagnosed with a true congenital pancreatic cyst that was ultimately removed surgically, emphasizing just how uncommon this finding is in the pediatric population.²³ The exact mechanism behind their formation during embryonic development is not well understood, but they are believed to arise from abnormal budding or duplication of the pancreatic ductal system.

Why So Many Cysts Are Found by Accident

A generation ago, most pancreatic cysts were discovered because they caused symptoms: abdominal pain, nausea, a palpable mass. Today, the majority are found incidentally when someone gets a CT scan or MRI for an unrelated reason. The widespread use of high-resolution cross-sectional imaging has dramatically increased the detection of these lesions.²⁴ Estimates of how many people walking around have an asymptomatic pancreatic cyst vary, but the numbers are high enough that managing incidental cysts has become a routine part of gastroenterology. The challenge is that imaging alone often cannot definitively tell a harmless serous cystadenoma from a mucinous cyst that could eventually become malignant.

How Doctors Tell Cyst Types Apart

Figuring out what kind of cyst someone has involves layering multiple types of information. Clinical history matters: a patient with a recent bout of pancreatitis and a new fluid collection almost certainly has a pseudocyst, while a young woman with a mixed solid-and-cystic mass in the tail of the pancreas likely has a solid pseudopapillary neoplasm or an MCN. Imaging with CT, MRI, and endoscopic ultrasound provides structural clues, such as whether the cyst communicates with the pancreatic duct (suggesting an IPMN) or sits in isolation (more typical of an MCN or serous cystadenoma).

When imaging is ambiguous, doctors can sample the cyst fluid using a needle guided by endoscopic ultrasound. The fluid’s chemical makeup and molecular profile can be highly informative. A systematic review and meta-analysis found that testing cyst fluid for two specific gene mutations, KRAS and GNAS, together achieved a pooled sensitivity of 94% and specificity of 91% for identifying IPMNs, significantly outperforming older fluid markers used alone.²⁵ These mutations are remarkably specific to mucin-producing cysts. One study found that GNAS mutations showed 100% specificity for mucinous cysts, meaning if the mutation was present, the cyst was virtually certain to be mucinous.²⁶

When a Cyst Needs Watching and When It Needs Removal

The question that weighs on most people after learning they have a pancreatic cyst is whether it could turn into cancer. For pseudocysts and serous cystadenomas, the answer is essentially no. For mucinous cysts, including IPMNs and MCNs, there is real but variable risk, and the decision about surveillance versus surgery depends on the cyst’s features.

Size and growth rate are among the strongest predictors. A meta-analysis of low-risk IPMNs found that cysts measuring 15 millimeters or smaller were substantially less likely to develop worrisome features or malignancy, and cysts that grew slowly, at less than about two millimeters per year, had dramatically lower cancer risk.²⁷ Conversely, a study of small pancreatic cysts tracked over time found that a growth rate of 2.5 millimeters per year or more was a powerful predictor of malignancy, and the development of new worrisome features on imaging, like a solid nodule within the cyst or dilation of the main pancreatic duct, also strongly predicted cancer.²⁸

For many people with small, stable, branch-duct IPMNs, the recommended approach is periodic surveillance with imaging, often starting annually and extending to longer intervals if the cyst remains unchanged. MCNs are more commonly removed because of their inherent malignant potential and the fact that they do not communicate with the duct system, making fluid sampling less reliable. Main-duct IPMNs carry enough risk that surgery is often recommended regardless of size. Serous cystadenomas, once confidently identified, can generally be left alone unless they cause symptoms from sheer bulk.

Hormonal Influences on Cyst Behavior

The connection between hormones and MCNs raises practical questions for women of reproductive age. If a woman is diagnosed with an MCN, her doctor will weigh whether hormonal treatments, including fertility treatments, could stimulate the tumor’s growth. The case of an MCN rupturing after IVF-related hormonal stimulation is a vivid illustration of why this matters.⁸ The presence of estrogen and progesterone receptors in MCN tissue suggests these tumors are not just incidentally more common in women but are biologically responsive to female sex hormones.⁷ This is an area where the science is still evolving, but it has clear implications for treatment planning in premenopausal women with known MCNs.

1
PubMed Central. Pancreatic pseudocyst or a cystic tumor of the pancreas?
2
PubMed Central. Comparative study of the outcome between alcohol and gallstone pancreatitis in a high‐volume tertiary care center
3
PubMed Central. Pancreatic pseudocyst in a child due to blunt abdominal trauma during a football game
4
PubMed Central. Analysis of Pancreatic Cyst Fluid
5
BMC Gastroenterol. Dilated common bile duct is commonly associated with main duct Intraductal Papillary Mucinous Neoplasm of the pancreas
6
PubMed. Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer
7
Scientific Reports. Intralobular distribution of ovarian-like stroma in pancreatic mucinous cystic neoplasms: a discussion on its tumorigenesis
8
PubMed Central. Growth and rupture of pancreatic mucinous cystic neoplasm following hormonal stimulation for in vitro fertilization: a case report
9
PubMed. Serous Cystadenoma of the Pancreas: An Easily Missed Cytological Diagnosis and Clues to Diagnosis
10
PubMed. Benign macrocystic serous cystadenoma of the pancreas
11
International Surgery Journal. Distal pancreatectomy with preserved spleen for benign serous cystadenoma of the pancreas
12
The American Journal of Pathology. Solid-Pseudopapillary Tumors of the Pancreas Are Associated with Mutations in the APC/β-Catenin Signaling Pathway
13
PubMed. Management recommendations for pancreatic manifestations of von Hippel-Lindau disease
14
PubMed Central. Pancreatic cyst development: insights from von Hippel-Lindau disease
15
PubMed Central. Pancreatic manifestations in von Hippel–Lindau disease: A case report
16
PubMed Central. Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease: Prevalence and Association with PKD2 Gene Mutations
17
PubMed Central. Pancreatic Cysts and Intraductal Papillary Mucinous Neoplasm in Autosomal Dominant Polycystic Kidney Disease
18
PubMed Central. Cystic Lesions in Autoimmune Pancreatitis
19
PubMed Central. A Case of Autoimmune Pancreatitis Manifested by a Pseudocyst and IgG4-Associated Cholangitis
20
PubMed. Pancreatico-renal fistula associated with pancreatic cysts caused by type 1 autoimmune pancreatitis
21
PubMed Central. Primary hydatid cyst of pancreas: Case report and review of literature
22
PubMed Central. Hydatid cyst of the pancreas causing portal hypertension
23
PubMed Central. True Congenital Pancreatic Cyst: A Rare Entity
24
PubMed. Pancreatic Cystic Lesions and Malignancy: Assessment, Guidelines, and the Field Defect
25
PubMed. Molecular analysis of EUS-acquired pancreatic cyst fluid for KRAS and GNAS mutations for diagnosis of intraductal papillary mucinous neoplasia and mucinous cystic lesions: a systematic review and meta-analysis
26
PubMed Central. Clinical Benefits of KRAS/GNAS Gene Mutation Analysis in Addition to Morphology and Conventional Cyst Fluid Testing in Differentiating Pancreatic Cysts
27
PubMed Central. Small cyst size and lack of growth as negative predictors of malignant transformation in low-risk intraductal papillary mucinous neoplasms of the pancreas: A systematic review and meta-analysis
28
PubMed Central. Risk of malignancy in small pancreatic cysts decreases over time